Even before COVID-19 set off a global tsunami of anxiety and depression, psychedelic drugs were already showing exciting promise for treating these and other intractable mental health conditions. Compass Pathway’s recent raise of $80M to expand research into the clinical uses of psilocybin only affirms that no coronavirus is going to dampen efforts to make … Read More »
psychedelic drugs
Microdosed LSD: Finally A Breakthrough For Alzheimer’s Disease?
(this article first appeared on Feb. 21, 2020) After decades of effort and untold millions invested in the search for an effective treatment for Alzheimer’s, the disease remains unchecked and rampant. Most recently, the New York Times reported that researchers declared defeat after the failure of yet another experimental drug designed to fight the formation of the … Read More »